Articles tagged with Cell Apoptosis
A new compound has been found to selectively kill cancerous cells while leaving healthy white blood cells intact. The compound, called 13-D, induces apoptosis in cancer cells by activating caspase-3 and causing cell shrinkage, a desirable outcome as it reduces the risk of side effects.
Researchers found that levels of apoptotic endothelial cells in lupus patients correlated with their vascular function and symptoms, suggesting a high risk of heart disease. The study suggests that lupus patients' heightened heart risk may be due to the rapid death and slow replacement of endothelial cells.
Researchers at St. Jude Children's Research Hospital have discovered that PUMA is the primary mediator of cell death in response to p53 signals, leading to apoptosis in cancer cells. The study provides critical insights into how cancer disrupts a failsafe mechanism that kills abnormal cells, and offers potential new therapy targets.
Researchers found that EPO reduced programmed cell death in heart cells, leading to smaller infarcts and increased heart function. The study suggests that EPO may offer novel protection against ischemic events in patients with acute coronary syndrome.
Researchers have developed a new test that can identify patients who may suffer serious late toxicity from radiotherapy. The test uses T-lymphocyte apoptosis to predict the risk of late toxicity and can help stratify patients for more aggressive treatment, resulting in improved cancer control with reduced side effects.
Scientists discover 'synoviolin', an enzyme that contributes to RA progression by over-growing synovial cells. Reducing synoviolin levels could halt joint destruction, offering new insights into RA etiology and innovative therapies.
A Northwestern University team created a compound that inhibits death-associated protein kinase, reducing brain cell death after injury or stroke. The treatment has shown protection for up to six hours post-injury and can last for weeks.
Scientists at Wake Forest are studying the genetic defects that allow cancer cells to resist cell death, in hopes of developing new treatments. They will use normal cells converted into cancer cells through controlled mutations to understand how resistance occurs.
Consuming phytoestrogens found in plant foods like soy is associated with a reduced risk of endometrial cancer. Imiquimod has been shown to induce apoptosis in skin cancer cells, while an integrin polymorphism may increase cancer progression. The study on breast cancer survivors also found increased numbers of circulating T lymphocytes.
Recent studies establish that beta-amyloid activates caspases, cutting tau at its tangle-blocking end and generating abnormal filaments. This process occurs before neuronal apoptosis, promoting death of the neuron.
Researchers have developed molecular markers that can predict radiation-induced late toxicity and disease recurrence in prostate cancer. The study used apoptosis assays to evaluate cell death induced by radiation, revealing correlations between lymphocyte apoptosis and toxicities.
UCSD researchers define multiple steps initiated by COX-2 enzymes, including cyclic adenosine monophosphate and Inhibitors of Apoptosis, leading to suppressed cell killing and uncontrolled growth. The study also explains how aspirin and NSAIDs can reduce colon cancer incidence by inhibiting COX-2.
Researchers discovered a new way to trigger self-destruction of certain cancer cells by targeting specific molecules. By blocking the action of a protein called mTOR, scientists can activate apoptosis in cancer cells lacking a gene called p53, leading to cell death.
A study by Mayo Clinic researchers found that a specific Vpr mutation is associated with long-term nonprogressive HIV infection, where infected individuals exhibit preserved immune function. The discovery suggests a potential therapeutic opportunity for Vpr inhibitors to reduce T cell death during HIV infection.
Scientists have made significant discoveries in the treatment of sinus node dysfunction, lupus, and cardiac failure, while also uncovering new mechanisms for bacterial defense and asthma treatment. These findings hold promise for developing more effective therapies.
Researchers discovered that humanin binds to Bax, preventing its targeting to mitochondria and blocking apoptosis. This finding suggests novel therapeutic approaches to prevent diseases associated with Bax activation.
A team of researchers found that the absence of a specific gene, Ink4d, causes progressive hearing loss in mice by triggering the death of sensory hair cells. This finding suggests that humans with similar genetic mutations may be more susceptible to hearing loss due to trauma.
UCSD researchers found that the Staph protein SpA triggers a pre-emptive attack on B cells, leading to their death and preventing them from developing memory cells. This process may explain why staph infections are common and recurring. The study's findings have potential applications in treating autoimmune diseases and cancers.
A University of Minnesota study has found that tauroursodeoxycholic acid (TUDCA) significantly reduces injury associated with hemorrhagic strokes in rats. The bile acid crosses the blood-brain barrier and induces survival pathways while inhibiting destructive ones, leading to a 50% decrease in lesion volume.
Researchers investigate targeting pericytes and endothelial cells with kinase inhibitors to treat cancer and autoimmune diseases. PDX1 levels also play a crucial role in islet survival and diabetes development, while Factor H's anti-inflammatory properties are explored for hemolytic uremic syndrome treatment.
Researchers at Cyclis Pharmaceuticals have discovered a new mechanism for treating cancer, involving the activation of the E2F1 protein with small molecule drugs. The findings, published in the Proceedings of the National Academy of Sciences, show that this approach can selectively kill cancer cells while sparing normal cells.
Researchers at University of Pittsburgh Medical Center found that deleting the PUMA gene in colorectal cancer cells prevents cell death. The study builds on previous findings and suggests that increasing PUMA levels could lead to new cancer therapies.
Scientists at Cold Spring Harbor Laboratory develop a new method to set the level of gene activity in stem cells using RNA interference, revealing distinct forms of lymphoma based on p53 levels. The study establishes RNAi as a convenient alternative to traditional gene knockout strategies.
Researchers have found that dietary grain affects colonic hydration, leading to significant changes in gut function. The study suggests that switching from hay only to hay and grain can decrease water content in the colon.
Researchers have made significant progress in understanding the effects of HIV protease inhibitors on atherosclerosis, as well as exploring novel gene therapies for epidermolysis bullosa. Additionally, studies on CXCR4/CXCL12 interaction reveal new insights into hematopoietic stem cell mobilization.
Scientists have discovered that BID protein plays a crucial role in regulating apoptosis of myeloid cells, which are prone to developing CMML. In mice genetically engineered to lack BID, researchers found an overexpansion of myeloid cells leading to leukemia, highlighting potential tumor suppression roles for other BH3-only proteins.
Researchers found that calorie-restricted diets reduced levels of proteins linked to cell death and increased beneficial protein ARC, which prevents neuron death. The findings have significant implications for alleviating memory loss and mental declines associated with aging.
Researchers at UNC used antisense oligonucleotides to target RNA splicing pathways implicated in cancer and genetic diseases. The technique successfully sensitized cancer cells to chemotherapy and radiation, offering a potential breakthrough for targeted therapy.
Researchers inserted a firefly gene into mice with cancer, allowing them to detect cell death in real-time. The technology uses luciferase to emit light only when cells start dying, enabling rapid testing of new drugs for cancer and other diseases.
Researchers at the University of Pennsylvania School found that the West Nile virus capsid protein can cause inflammation and apoptosis in cells, leading to encephalitic inflammation. The study suggests that blocking the protein's pathogenicity may help slow down the virus.
Researchers developed new compounds to optimize apoptosis-inducing ability of celecoxib, a COX-2 inhibitor. They found that the structural features required for apoptosis induction differ from those required for COX-2 inhibition.
A recent study reveals that sperm in men older than 35 show more DNA damage, which could be passed on to offspring. The researchers found that older men have lower motility and more damaged DNA, with fewer apoptotic cells, indicating a decline in the ability of sperm to eliminate damaged cells.
Researchers found that ICAD-deficient flies lack apoptotic DNA fragmentation due to impaired CAD protein expression. Meanwhile, DNase II-deficient flies accumulate fragmented DNA and trigger an immune response. This study reveals a crucial role for innate immunity in apoptotic DNA degradation.
Healthy, nondividing cells have a biochemical switch that triggers apoptosis when inactivated by deamidation of Bcl-xL protein. This discovery suggests that tumor cells with the same switch may be resistant to chemotherapy drugs.
Researchers at Memorial Sloan Kettering Cancer Center discovered that cancer cells containing high levels of Myc protein cannot activate p21 gene production, leading to cell death. The study's findings suggest a potential strategy to increase chemotherapy effectiveness by favoring apoptosis over citostasis.
Researchers discovered a mutation in the caspase-8 gene in two siblings with an immune disorder, which led to impaired lymphocyte activation and severe immunodeficiency. The study found that functional caspase-8 restored immune cell function, suggesting its potential as a target for new therapies.
Researchers have isolated a key component of cell death signals that can be targeted to prevent cancer growth. By understanding how these signals interact, scientists hope to develop new anti-cancer therapies.
Researchers at Temple University have discovered that combining the Rb2 gene with gamma radiation treatment speeds up tumor cell death by upregulating p73 and downregulating Bcl-2. This study offers a promising new approach to treating glioblastoma, a malignant brain tumor.
Researchers discovered that tauroursodeoxycholic acid (TUDCA) can cross the blood-brain barrier and reduce apoptosis in mice with the HD gene, improving neurological cell function. The bile acid's anti-apoptotic qualities may also have potential for treating other chronic neurodegenerative conditions.
Scientists have identified a key trigger of neuron death in Parkinson's disease, stroke, and traumatic brain injury, which can be prevented by blocking its release from mitochondria. The study found that preventing PARP activation and blocking AIF release protects cells from dying.
Researchers have identified organosulfur compounds, such as ADT, as effective in preventing lung cancer progression. Vitamin B12 analogues also showed promise in targeting chemotherapy drugs to tumor cells, while aminopeptidase inhibitors may help restore apoptosis in leukemia cells
Researchers found that melanocytes, pigment-producing skin cells, are resistant to chemotherapy and radiation due to a protective mechanism involving the MITF gene. This mechanism allows them to survive solar radiation, making melanoma treatment challenging.
Researchers at Rockefeller University have discovered that the 'Reaper' protein triggers programmed cell death by instructing a fly cell's principal guard protein, DIAP1, to self-destruct. This finding may lead to novel strategies for targeting immortal cancer cells without harming healthy cells.
Apoptosis, a programmed cell death mechanism, has been linked to herpes simplex encephalitis (HSE), a devastating brain infection. The study found that apoptotic cells were present in HSE patients and correlated with active infection and tissue injury.
Researchers found celecoxib induces cell death without blocking COX-2 enzyme. Alternate mechanism involves decreased phosphorylation of Akt and ERK2 proteins. Newer generations of COX-2 inhibitors may be safer and more effective for colon cancer treatment.
CP461 acts against cancer cells selectively through both apoptosis and anti-angiogenic effects, preventing new blood vessel formation. The compound also disrupts microtubule organization and proper spindle formation, blocking mitosis and promoting cell death in cancer cells.
Research on spermatocyte apoptosis highlights the role of cell-cell and cell-extracellular matrix interactions. Key findings include specific molecular pathways involved in regulating spermatocyte death, which may inform therapeutic strategies for male infertility and other reproductive disorders.
Researchers have discovered a new target for treating cancer cells that rely on survivin to survive. This finding offers new hope for patients with cancer who are struggling with this aggressive protein.
Scientists have determined the three-dimensional structure of Death Associated Protein Kinase (DAPK) and created a quantitative assay to measure its activity. This breakthrough may lead to new drugs that can reduce cell damage following brain injuries and strokes.
A study published in Molecular Psychiatry found that maternal separation causes the death of brain cells. However, researchers discovered that fluoxetine, a type of Prozac, can reverse these changes and promote cell growth in the dentate gyrus of rats.
Recent research highlights the significance of sodium-calcium exchange in various physiological processes, including vision, secretion, and cardiac contractility. The study also explores its potential applications in cancer therapy and heart function.
Researchers have discovered two distinct pathways leading to cell death in the diseased kidney, which could lead to new therapeutic targets for kidney disease. These findings provide a better understanding of kidney pathology and may enable the development of more effective treatments.
Researchers have found that leukemia cells resist apoptosis due to constitutive activation of STAT3 and/or STAT1. AG-490, a JAK inhibitor, promotes apoptosis in these cells by blocking STAT3 function.
Researchers at Virginia Tech found that stimulating a mother's immune system can increase growth factors in the fetus, reducing birth defects. The study suggests a new role for maternal immunity in fetal development, potentially unlocking secrets to reversing certain birth defects.
Idun Pharmaceuticals recreates key apoptosis reaction to understand mechanism of programmed cell death. The company screens new drugs modulating apoptosis using the assay, aiming to treat cancers, heart attacks, and strokes.
Researchers found that malignant melanomas often lose the protein Apaf-1, leading to resistance to chemotherapy drug adriamycin. Restoring Apaf-1 in melanoma cells rescues their ability to kill themselves in response to adriamycin.
Researchers identified SAANDS compounds as a potential new drug target for inducing apoptosis in abnormal cells. The compounds inhibit cGMP phosphodiesterases, triggering programmed cell death in cancerous and precancerous cells.
Researchers found that telomerase blocks a biochemical cascade of reactions called apoptosis, which causes nerve cell self-destruction. High levels of telomerase display remarkable resistance to damage or death in experimental models of Alzheimer's disease or stroke.
Familial adenomatous polyposis (FAP) patients treated with Aptosyn experienced a clinically significant reduction in precancerous colon polyp formation after six months of therapy. Over 18 months, patients showed an overall 75% reduction in polyps, highlighting the compound's potential as a treatment for FAP.
Researchers discovered two molecular switches, Jnk1 and Jnk2, that stimulate programmed cell death in response to UV radiation. Disrupting these genes protects cells from lethal doses of UV light, providing a promising new therapy for diseases such as strokes and heart attacks.